PATENT CLAIM ANALYSIS

Application Number: 16129470
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "459000"]

Abstract:
This disclosure concerns the discovery of the use of fenoterol and (R,R)- and (R,S)-fenoterol analogues for the treatment of a tumor expressing a β2-adrenergic receptor, such as a primary brain tumor, including a glioblastoma or astrocytoma expressing a β2-adrenergic receptor. In one example, the method includes administering to a subject a therapeutically effective amount of fenoterol, a specific fenoterol analogue or a combination thereof to reduce one or more symptoms associated with the tumor, thereby treating the tumor in the subject.

Claim (Index 8):
The method of  claim 1 , wherein cells of the pancreatic cancer or primary brain tumor express a \u03b22-adrenergic receptor.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15273147', '13583206', '16129569', '15225643', '15874747']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8066609932173472
- 35 USC 102 Novelty (BERT): 0.5499501889826472
- Combined Prediction Score: 0.7809899127938772
- Mean Citation Score: 349.140504
- Max Citation Score: 435.35867
- Similarity Product: 277.0209912346661

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test